维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="SARMAN S"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor(VEGF) in inflammation-associated corneal neovascularization 显示文摘	Kuanta A Sarman S Fagerholm P	2000	Exp Eye Res2000，70，4：	1
2	Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization显示文摘	Kvanta A Shen WY Sarman S	2000	Curr Eye Res2000，21，：	1
3	Expression of matrix metalloproteinase-2 (MMP-2)and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization 显示文摘	Kvanta A Sarman S Fagerholm P	2000	Exp Eye Res2000，70，：	1
4	Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization 显示文摘	Kvanta A Shen WY Sarman S Seregard S Steen B Rakoczy E	2000	Curr Eye Res2000，21，：	1
5	Predicting kala azar disease manifestation in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen显示文摘	Sarman S Kumari V Singh N	2002	Clin diagn Lab Lmmun2002，9，3：	1
6	Reduced choroidat lar membrane formation in matrix metalloproteinase-2-deficient mice 显示文摘	Berglin L Sarman S der Ploeg I	2003	Invest Ophthalmol Vis Sci2003，44，：	1
7	Predicting Kala-azar disease manifes-tation in asym ptom atie patients with latent leishmania donovani infection by detection of antibody against recombinant K 39 antigen 显示文摘	Sarman S Kumari V Singh N	2002	Clinical and diagnostic I_aboratory Lmmunology2002，9，3：	1
8	Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization 显示文摘	Kvanta A Sarman S Fagerholm P	2000	Exp Eye Res2000，70，4：	1
9	Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice显示文摘	Berglin L Sarman S van der Ploeg I	2003	Invest Ophthamol Vis Sci2003，44，1：	1
10	Shipboard power restored for active duty 显示文摘	SRIVASTAVA S K BUTLER-PURRY K L SARMAN D R	2002	IEEE Computer Applications in Power2002，15，3：	1
11	Expression of matrix metalloproteinase-2(MMP-2)and vascular endothelial growth factor(VEGF)in inflammation-associated corneal neovascularization显示文摘	Kvanta A Sarman S Fagerholm P Seregard S Steen B	2000	Exp Eye Res2000，70，4：	1
12	Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice显示文摘	Berglin L Sarman S van der Ploeg I	2003	Invest Ophthamol Vis Sci2003，44，1：	1
13	Predicting kala-azar disease manifestation in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen显示文摘	Sarman S Kumari V Singh N	2002	Clin Diag Lab Immun2002，9，3：	1
14	Expression of matrix metalloproteinase-2(MMP-2)and vascular endothelial growth factor(VEGF)in inflammation associated corneal neovascularization 显示文摘	KVANTS A SARMAN S FAGERHOLM P et a1	2000	Exp Eye Res2000，70，：	1
15	Hepatitis C virus induced miR200cdown modulates FAP-1,a negative regulator of Src signaling and promotes hepatic fibrosis显示文摘	RAMACHANDRAN S ILIAS BASHA H SARMAN J	2013	PLoS One2013，8，70：	1
16	Anew 0-1 integer programming method of feeder reconfiguration for loss minimization in distribution systems 显示文摘	SarmaN D R Prakasa Rao K S	1995	Electrical Power System Research1995，，33：	1
17	Expression of matrix metalloproteinase-2( MMP-2) and vascular endothelial growth factor显示文摘	Kvanta A Sarman S Fagerholm P	2000	Exp Eye Res2000，70，4：	1
18	Expression of matrix metalloproteinase-2(MMP-2)and vascular endothelial growth factor(VEGF)in inflammation-associated corneal neovascularization显示文摘	Kvanta A Sarman S Fagerholm P	2000	Exp Eye Res2000，70，4：	1
19	Matrix metalloprotei nase (MMP) expression in experimental choroidal neovascu larization显示文摘	Kvanta A Shen W Y Sarman S	2000	Curt Eye Res2000，21，3：	1
20	Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice显示文摘	BERGLIN L SARMAN S VAN DER PLOEG I	2003	Invest Ophthalmol Vis Sci2003，44，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示